In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AGORACOM News Flash

Agoracom Update Complete.

Our system upgrade is now complete. If you encounter any problems, please notify us using our contact form

Thanks for your continued support in making Agoracom the best online community for Small Cap Investors.

Close
AlphaRx > Message
Generic_profile

Test Results

Posted by: drclaw on December 04, 2007 06:46PM

Agora,

in regards to the Sept 13 press release, and the statement "The Company has initiated two pivotal animal studies for ARX828 and expects to receive results from these studies for analysis, by end of November", could you request the management address the status of these results/analysis with their shareholders through a press release as soon as they are able to.

Thank you.

Did You Know?

The AGORACOM MarketPlace is a great place to find your next great small cap investment

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote